Vivo Capital IX, LLC

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Hongbo Lu, as a managing member of Vivo Opportunity, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vivo Capital IX, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. 10%+ Owner Common Stock 2,469,001 $49,380,020 $20.00 05 May 2022 Indirect
IO Biotech, Inc. 10%+ Owner Common Stock 3,157,894 $3,268,420 $1.04 09 Aug 2023 By Vivo Opportunity Fund Holdings, L.P.
IO Biotech, Inc. 10%+ Owner Common Stock 3,015,545 $3,121,089 $1.04 09 Aug 2023 By: Vivo Capital Fund IX, L.P.
IO Biotech, Inc. 10%+ Owner Common Stock 3,015,545 $3,121,089 $1.04 09 Nov 2021 Direct
IO Biotech, Inc. 10%+ Owner Warrants (Right to Buy) 3,157,894 09 Aug 2023 By Vivo Opportunity Fund Holdings, L.P.
IO Biotech, Inc. 10%+ Owner Series C Preferred Stock 0 09 Nov 2021 Direct

Insider Reports Filed by Vivo Capital IX, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IOBT IO Biotech, Inc. 09 Aug 2023 2 +$6,394,735 4 10%+ Owner 10 Aug 2023, 09:03
TARS Tarsus Pharmaceuticals, Inc. 05 May 2022 1 -$65,832 4 10%+ Owner 05 May 2022, 18:55
TARS Tarsus Pharmaceuticals, Inc. 02 May 2022 3 -$6,866,311 4 10%+ Owner 04 May 2022, 20:01
IOBT IO Biotech, Inc. 09 Nov 2021 3 +$9,100,000 4 10%+ Owner 12 Nov 2021, 15:16
IOBT IO Biotech, Inc. 04 Nov 2021 0 $0 3 10%+ Owner 04 Nov 2021, 21:33
TARS Tarsus Pharmaceuticals, Inc. 23 Jun 2021 3 -$1,658,842 4 10%+ Owner 25 Jun 2021, 21:30
TARS Tarsus Pharmaceuticals, Inc. 21 Jun 2021 2 -$5,856,114 4 10%+ Owner 25 Jun 2021, 20:51